Fife, United Kingdom

David Moody

This inventor holds 1 USPTO granted patent. Top assignees: Merck + Co., Inc., Zeneca Limited. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Moody. Retrieved from https://idiyas.com/inventor/david-moody-0c1es50c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of David Moody

Introduction

David Moody is an accomplished inventor based in Fife, GB. He is known for his significant contributions to the field of chemistry, particularly in the synthesis of important compounds. His work has implications in the medical field, especially concerning treatments for glaucoma.

Latest Patents

David Moody holds a patent for the "Synthesis of hydroxysulfone and related compounds." This invention focuses on an improved process for synthesizing hydroxysulfone, which serves as a key intermediate in the development of carbonic anhydrase inhibitors, notably dorzolamide. Carbonic anhydrase inhibitors are recognized for their effectiveness in treating elevated intraocular pressure or glaucoma.

Career Highlights

Throughout his career, David Moody has worked with prominent companies such as Merck & Co., Inc. and Zeneca Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical chemistry.

Collaborations

David has collaborated with notable colleagues, including David J Mathre and Paul Sohar. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

David Moody's innovative work in the synthesis of hydroxysulfone highlights his contributions to medical chemistry and the treatment of glaucoma. His patent and collaborations reflect a commitment to advancing scientific knowledge and improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…